Trans People in the U.S.: Identities, Demographics, and Wellbeing September 28, 2023 Issue Brief The recently released KFF/Washington Post Trans Survey is the most in-depth, representative survey of transgender adults living in the U.S. Building on that report, and using the survey data, this analysis provides the most comprehensive representative profile of trans Americans ever complied, while also offering insights on their experiences in the health care system.
Poll: Nearly Half of Adults Expect to Get the New COVID-19 Vaccine, But Most Parents Don’t Expect to Get It for Their Children; More Eligible Adults Expect to Get a Flu Shot and the New RSV Vaccine September 27, 2023 News Release Nearly half of adults say that they will “definitely” or “probably” get the newly recommended COVID-19 vaccine, though most parents are not planning to get the shot for their children, according to the latest KFF COVID-19 Vaccine Monitor poll. Among all adults, 23% say they will definitely get the new…
KFF COVID-19 Vaccine Monitor September 2023: Partisanship Remains Key Predictor of Views Of COVID-19, Including Plans To Get Latest COVID-19 Vaccine September 27, 2023 Poll Finding This poll finds that nearly half of the public expects to get the new COVID-19 vaccine, which was recently recommended by the CDC,. About 6 in 10 expect to get a flu shot. The survey also examines attitudes about COVID-19 and vaccine safety, and the RSV vaccine. It also examines partisan divisions around vaccines.
Private Insurer Payments for Telehealth and In-Person Claims During the Pandemic September 26, 2023 Issue Brief This analysis of 2021 claims data finds that while telehealth use remained high in the second year of the COVID-19 pandemic, the shift toward virtual physician and mental health care did not materially affect how much insurers paid for each patient encounter.
How Medicare’s New Drug Price Negotiation Program Could Expand Access to Selected Drugs September 26, 2023 Issue Brief This brief examines how Part D enrollees’ access to and utilization of the first set of 10 selected drugs could be affected by the new Part D coverage and formulary requirements for selected drugs established by the Inflation Reduction Act and in CMS guidance, as well as the potential for lower out-of-pocket costs.
Insurance Coverage of Updated COVID-19 Vaccines: A Cheat Sheet September 22, 2023 Infographic This cheat sheet provides details on coverage rules by insurance type and for people who are uninsured.
As Congress Considers Reauthorization of PEPFAR, KFF Examines the Role of Abortion September 22, 2023 News Release As Congress considers reauthorization of the President’s Emergency Plan for AIDS Relief (PEPFAR) for a fourth time, KFF explores the debate over abortion policy that has stalled the legislation and the potential implications if Congress does not reauthorize the program. PEPFAR spans more than 50 countries and has been reported…
The U.S. & The Global Fund to Fight AIDS, Tuberculosis and Malaria September 22, 2023 Fact Sheet This updated fact sheet examines the U.S. role in the Global Fund, an independent, multilateral financing entity that raises significant new resources to combat HIV/AIDS, tuberculosis (TB), and malaria in low- and middle- income countries.
PEPFAR Reauthorization: The Debate About Abortion September 21, 2023 Blog This policy watch provides an overview of the current debate and key questions related to abortion surrounding the fourth reauthorization of PEPFAR.
Marketing Medicare – How Health Insurers and Brokers Use TV Ads to Attract Enrollees September 20, 2023 Event KFF held a web event on September 20, 2023 to discuss Medicare marketing practices in advance of the open enrollment period, which begins Oct. 15. As part of the event, KFF released a new analysis of television ads that aired during last year’s open enrollment season and share insights from…